Literature DB >> 17936555

Inflammation and cancer: a double-edged sword.

Thorsten Hagemann1, Frances Balkwill, Toby Lawrence.   

Abstract

Recent literature has highlighted an important role of inflammation in promoting cancer. However, the immune system can also play a central role in protecting the body against cancer as well as infection, although its role in cancer is not well understood. A study published in the September issue of Nature Medicine adds a new twist to the role of inflammation in cancer. Apetoh et al. describe how activation of innate immunity after conventional radiation or chemotherapy can trigger protective antitumor immunity.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17936555      PMCID: PMC2592547          DOI: 10.1016/j.ccr.2007.10.005

Source DB:  PubMed          Journal:  Cancer Cell        ISSN: 1535-6108            Impact factor:   31.743


  12 in total

Review 1.  BCG (Bacillus of Calmette Guerin) therapy of high-risk superficial bladder cancer.

Authors:  PierFrancesco Bassi
Journal:  Surg Oncol       Date:  2002-06       Impact factor: 3.279

Review 2.  Tumour-educated macrophages promote tumour progression and metastasis.

Authors:  Jeffrey W Pollard
Journal:  Nat Rev Cancer       Date:  2004-01       Impact factor: 60.716

Review 3.  Smoldering and polarized inflammation in the initiation and promotion of malignant disease.

Authors:  Frances Balkwill; Kellie A Charles; Alberto Mantovani
Journal:  Cancer Cell       Date:  2005-03       Impact factor: 31.743

Review 4.  Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes.

Authors:  Alberto Mantovani; Silvano Sozzani; Massimo Locati; Paola Allavena; Antonio Sica
Journal:  Trends Immunol       Date:  2002-11       Impact factor: 16.687

Review 5.  High-mobility group box 1 protein (HMGB1): nuclear weapon in the immune arsenal.

Authors:  Michael T Lotze; Kevin J Tracey
Journal:  Nat Rev Immunol       Date:  2005-04       Impact factor: 53.106

6.  IKKbeta links inflammation and tumorigenesis in a mouse model of colitis-associated cancer.

Authors:  Florian R Greten; Lars Eckmann; Tim F Greten; Jin Mo Park; Zhi-Wei Li; Laurence J Egan; Martin F Kagnoff; Michael Karin
Journal:  Cell       Date:  2004-08-06       Impact factor: 41.582

7.  Toll-like receptor 4-dependent contribution of the immune system to anticancer chemotherapy and radiotherapy.

Authors:  Lionel Apetoh; François Ghiringhelli; Antoine Tesniere; Michel Obeid; Carla Ortiz; Alfredo Criollo; Grégoire Mignot; M Chiara Maiuri; Evelyn Ullrich; Patrick Saulnier; Huan Yang; Sebastian Amigorena; Bernard Ryffel; Franck J Barrat; Paul Saftig; Francis Levi; Rosette Lidereau; Catherine Nogues; Jean-Paul Mira; Agnès Chompret; Virginie Joulin; Françoise Clavel-Chapelon; Jean Bourhis; Fabrice André; Suzette Delaloge; Thomas Tursz; Guido Kroemer; Laurence Zitvogel
Journal:  Nat Med       Date:  2007-08-19       Impact factor: 53.440

8.  Gender disparity in liver cancer due to sex differences in MyD88-dependent IL-6 production.

Authors:  Willscott E Naugler; Toshiharu Sakurai; Sunhwa Kim; Shin Maeda; Kyounghyun Kim; Ahmed M Elsharkawy; Michael Karin
Journal:  Science       Date:  2007-07-06       Impact factor: 47.728

9.  IKKbeta is required for prevention of apoptosis mediated by cell-bound but not by circulating TNFalpha.

Authors:  Shin Maeda; Lufen Chang; Zhi-Wei Li; Jun-Li Luo; Hyam Leffert; Michael Karin
Journal:  Immunity       Date:  2003-11       Impact factor: 31.745

10.  Cancer. Sex, cytokines, and cancer.

Authors:  Toby Lawrence; Thorsten Hageman; Frances Balkwill
Journal:  Science       Date:  2007-07-06       Impact factor: 47.728

View more
  51 in total

Review 1.  Biobehavioral factors and cancer progression: physiological pathways and mechanisms.

Authors:  Susan K Lutgendorf; Anil K Sood
Journal:  Psychosom Med       Date:  2011-10-21       Impact factor: 4.312

Review 2.  Important aspects of Toll-like receptors, ligands and their signaling pathways.

Authors:  Z L Chang
Journal:  Inflamm Res       Date:  2010-07-01       Impact factor: 4.575

3.  Tumor endothelin-1 enhances metastatic colonization of the lung in mouse xenograft models of bladder cancer.

Authors:  Neveen Said; Steven Smith; Marta Sanchez-Carbayo; Dan Theodorescu
Journal:  J Clin Invest       Date:  2010-12-22       Impact factor: 14.808

4.  NF-κB pathway in colitis-associated cancers.

Authors:  Emilie Viennois; Fengyuan Chen; Didier Merlin
Journal:  Transl Gastrointest Cancer       Date:  2013-01-01

5.  Aging attenuates radiation-induced expression of pro-inflammatory mediators in rat brain.

Authors:  Won Hee Lee; William E Sonntag; Yong Woo Lee
Journal:  Neurosci Lett       Date:  2010-04-10       Impact factor: 3.046

Review 6.  Cancer and inflammation.

Authors:  Lance L Munn
Journal:  Wiley Interdiscip Rev Syst Biol Med       Date:  2016-12-12

Review 7.  The tumor microenvironment and its contribution to tumor evolution toward metastasis.

Authors:  Girieca Lorusso; Curzio Rüegg
Journal:  Histochem Cell Biol       Date:  2008-11-06       Impact factor: 4.304

8.  Combinatorial pharmacologic approaches target EZH2-mediated gene repression in breast cancer cells.

Authors:  Feng Sun; Eli Chan; Zhenlong Wu; Xiaojing Yang; Victor E Marquez; Qiang Yu
Journal:  Mol Cancer Ther       Date:  2009-12       Impact factor: 6.261

Review 9.  Breast tumor microenvironment: proteomics highlights the treatments targeting secretome.

Authors:  Shui-Tein Chen; Tai-Long Pan; Hsueh-Fen Juan; Tai-Yuan Chen; Yih-Shyan Lin; Chun-Ming Huang
Journal:  J Proteome Res       Date:  2008-02-22       Impact factor: 4.466

10.  Activation of the NLRP3 inflammasome in dendritic cells induces IL-1beta-dependent adaptive immunity against tumors.

Authors:  François Ghiringhelli; Lionel Apetoh; Antoine Tesniere; Laetitia Aymeric; Yuting Ma; Carla Ortiz; Karim Vermaelen; Theocharis Panaretakis; Grégoire Mignot; Evelyn Ullrich; Jean-Luc Perfettini; Frédéric Schlemmer; Ezgi Tasdemir; Martin Uhl; Pierre Génin; Ahmet Civas; Bernhard Ryffel; Jean Kanellopoulos; Jürg Tschopp; Fabrice André; Rosette Lidereau; Nicole M McLaughlin; Nicole M Haynes; Mark J Smyth; Guido Kroemer; Laurence Zitvogel
Journal:  Nat Med       Date:  2009-09-20       Impact factor: 53.440

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.